Alerts will be sent to your verified email
Verify Email
KILITCH
|
Kilitch Drugs(India)
|
Gufic Biosciences
|
Ind-Swift
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.79 % | 26.14 % | 30.85 % |
|
5yr average Equity Multiplier
|
1.38 | 2.82 | -1.62 |
|
5yr Average Asset Turnover Ratio
|
0.5 | 1.1 | 0.48 |
|
5yr Avg Net Profit Margin
|
5.1 % | 9.03 % | -45.85 % |
|
Price to Book
|
3.37 | 8.25 | 0.0 |
|
P/E
|
38.72 | 38.29 | 4.45 |
|
5yr Avg Cash Conversion Cycle
|
-70.11 Days | -18.02 Days | -212.7 Days |
|
Inventory Days
|
19.8 Days | 77.22 Days | 74.98 Days |
|
Days Receivable
|
125.11 Days | 81.36 Days | 85.13 Days |
|
Days Payable
|
169.05 Days | 175.58 Days | 267.01 Days |
|
5yr Average Interest Coverage Ratio
|
7.08 | 10.3 | -6.47 |
|
5yr Avg ROCE
|
6.74 % | 33.27 % | -66.14 % |
|
5yr Avg Operating Profit Margin
|
12.08 % | 17.37 % | -5.79 % |
|
5 yr average Debt to Equity
|
0.12 | 0.73 | -2.08 |
|
5yr CAGR Net Profit
|
22.23 % | 29.43 % | n/a |
|
5yr Average Return on Assets
|
2.69 % | 10.17 % | -16.74 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.23 % | 72.51 % | 55.58 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 42.81 % |
|
Change in Promoter Holding (3 Yrs)
|
0.6 % | 6.76 % | 0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -6.16 % | 0.0 |
|
Kilitch Drugs(India)
|
Gufic Biosciences
|
Ind-Swift
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
